AN INVESTIGATION OF THE CLINICAL IMPACT OF BETA2-AGONIST USE IN HEART FAILURE

被引：0
|
作者：
Bermingham, M. [1 ]
O'Callaghan, E. [1 ]
Dawkins, I [1 ]
Miwa, S. [1 ]
Samsudin, S. [1 ]
McDonald, K. [1 ]
Ledwidge, M. [1 ]
机构：
[1] St Vincents Univ Hosp, Heart Failure Unit, Dublin 4, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2010年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
10
引用
收藏
页码：S388 / S388
页数：1
相关论文
共 50 条
  • [41] Beta2-Agonist Doping Control and Optical Isomer Challenges (vol 46, pg 1787, 2016)
    Jacobson, Glenn A.
    Fawcett, J. Paul
    [J]. SPORTS MEDICINE, 2018, 48 (06) : 1523 - 1523
  • [42] Protective effect of inhaled glucocorticosteroid and long-acting beta2-agonist combination on COPD model
    Titova, Olga
    Kuzubova, Natalya
    Lebedeva, Elena
    Volchkova, Elizaveta
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [43] A NEW BETA-2 ADRENOCEPTOR AGONIST (PIRBUTEROL) IN THE TREATMENT OF ISCHEMIC HEART-FAILURE
    NELSON, GIC
    SILKE, B
    BARKER, MCJ
    SAXTON, CAPD
    TAYLOR, SH
    [J]. EUROPEAN HEART JOURNAL, 1982, 3 (03) : 238 - 245
  • [44] Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children
    Cates, Christopher J.
    Lasserson, Toby J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [45] HIGH-DOSE BETA2-AGONIST TREATMENT IS ASSOCIATED WITH CARDIAC DYSFUNCTION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Shafuddin, E.
    Cooray, M.
    Tuffery, C.
    Hopping, S.
    Sullivan, G.
    Jacobson, G.
    Chang, C.
    Hancox, R.
    [J]. RESPIROLOGY, 2016, 21 : 24 - 24
  • [46] LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients
    Christiansen, Anders
    Titlestad, Ingrid L.
    Vestbo, Jorgen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [47] Agonist-like beta-adrenoceptor antibodies in heart failure
    Wallukat, G
    Müller, J
    Podlowski, S
    Nissen, E
    Morwinski, R
    Hetzer, R
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (12A): : 75H - 79H
  • [48] PIRBUTEROL - ORAL BETA AGONIST FOR THERAPY OF CONGESTIVE HEART-FAILURE
    SHARMA, B
    HOBACK, J
    FRANCIS, G
    HODGES, M
    ASINGER, RW
    COHN, JN
    TAYLOR, CR
    [J]. CIRCULATION, 1979, 60 (04) : 229 - 229
  • [49] Evaluating Different Physician's Prescribing Preference Based Instrumental Variables in the Study of Beta2-Agonist Use and the Risk of Acute Myocardial Infarction
    Uddin, Md Jamal
    Groenwold, Rolf H. H.
    de Boer, Anthonius
    Afonso, Ana
    Primatesta, Paola
    Becker, Claudia
    Belitser, Svetlana V.
    Hoes, Arno W.
    Roes, Kit C. B.
    Klungel, Olaf H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 32 - 32
  • [50] Clinical Impact of Heart Failure Support Team in the Management of Heart Failure
    Nakano, Yoshinori
    Dote, Keigo
    Kato, Masaya
    Sasaki, Shota
    Oda, Noboru
    Kagawa, Eisuke
    Sumimoto, Yoji
    Yamane, Aya
    Miura, Katsuya
    Takaeko, Yuji
    [J]. JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S153 - S153
12345